Zydus Cadila looking to supply COVID-19 vaccine ZyCoV-D by middle to end of September

23 Aug 2021 Evaluate

Zydus Cadila is looking to supply its COVID-19 vaccine ZyCoV-D by the middle to end of September, and the pricing of the dose will be announced in the next one or two weeks. The company's indigenously developed needle-free three-dose COVID-19 vaccine ZyCoV-D was granted emergency use authorisation (EUA) by the drug regulator, making it the first vaccine to be administered to beneficiaries in the age group of 12-18 years in the country.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Zydus Lifesciences Share Price

997.45 12.70 (1.29%)
15-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1528.20
Dr. Reddys Lab 5872.35
Cipla 1405.95
Zydus Lifesciences 997.45
Lupin 1638.40
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.